Why did ALNEV.PA stock drop so sharply today?

The 99.75% drop to **€0.0045** on EURONEXT coincided with very heavy volume. Such gaps often reflect a corporate action, trade irregularity or market revaluation. Confirmations should come from company filings and exchange notices before trading decisions.

What is Meyka AI's view on ALNEV.PA stock grading?

Meyka AI rates ALNEV.PA **58.13 out of 100** (C+, HOLD). The score balances sector comparisons, financial growth and analyst inputs, but it is informational and not personal financial advice.

Is there a realistic price target for ALNEV.PA stock?

A cautious base‑case target is **€0.01** if liquidity normalises, implying roughly **122.22%** upside from **€0.0045**. Targets depend on corporate disclosures and are not guarantees.

Should investors trade ALNEV.PA stock after this move?

Trading carries high risk due to low price, wide spreads and potential corporate events. Use small position sizes, limit orders and wait for official EURONEXT or company communications before increasing exposure.

EU Stocks

ALNEV.PA Neovacs S.A. falls 99.75% on EURONEXT 19 Jan 2026: key liquidity risks

ByDanny Kontos January 20, 2026January 20, 2026

ALNEV.PA stock closed the session on EURONEXT down 99.75% at €0.0045 on 19 Jan 2026, trading 18,884,618 shares. This sharp move makes Neovacs S.A. one of today’s top losers and raises immediate questions about liquidity, corporate actions and investor protection on the Europe market. We present concise metrics, Meyka AI grading, and a short forecast to frame the near-term outlook for traders and longer-term investors.